"Haik Humble Eye Center is proud to be the only practice in Northeast Louisiana that offers every aspect of eye care to the community. From eye examinations to complex surgical procedures, our members embrace the tradition of teamwork in providing vision care services. Over the past 35 years, above all else, it is our caring for people like you who has assured our sustained growth and expansion of services. Yet one thing hasn’t changed over the years: our commitment to providing the highest quality eye care. Our commitment, then and now is to exceed our patient’s expectation in quality care and service to the patient and family."

During the past decade, Eye Associates of Northeast Louisiana dba Haik Humble Eye Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eye Associates of Northeast Louisiana dba Haik Humble Eye Center" #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "Kowa Company, Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Eye Associates of Northeast Louisiana dba Haik Humble Eye Center" are "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (2 trials), "Bacterial Conjunctivitis" (1 trials), "Full-thickness Macular Holes (MH)" (1 trials) and "Proliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Eye Associates of Northeast Louisiana dba Haik Humble Eye Center" in a lesser frequency.

Most popular intervention types in "Eye Associates of Northeast Louisiana dba Haik Humble Eye Center" are "Drug" (5 trials), "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "Bevacizumab + Deferred Aflibercept Group" (1 trials), "Deferred aflibercept" (1 trials) and "Deferred laser" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Associates of Northeast Louisiana dba Haik Humble Eye Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Eye Associates of Northeast Louisiana dba Haik Humble Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Eye Associates of Northeast Louisiana dba Haik Humble Eye Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Eye Associates of Northeast Louisiana dba Haik Humble Eye Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".